Alembic reports 38% fall in Q4 consolidated net profit

12 May 2021 Evaluate

Alembic has reported results for fourth quarter and year ended March 31, 2021.

The company has reported a fall of 93.45% in its net profit at Rs 3.63 crore for the quarter under review as compared to Rs 55.46 crore for the same quarter in the previous year. Total income of the company decreased by 55.92% at Rs 30.26 crore for Q4FY21 as compared Rs 68.65 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 37.68% in its net profit and share of associate’s profit at Rs 71.94 crore for the quarter under review as compared to Rs 115.43 crore for the same quarter in the previous year. Total income of the company decreased by 55.41% at Rs 30.66 crore for Q4FY21 as compared Rs 68.76 crore for the corresponding quarter previous year.

For the year ended March 31, 2021, the company has reported a fall of 85.72% in its net profit at Rs 13.36 crore as compared to Rs 93.55 crore for the previous year. Total income of the company decreased by 50.48% at Rs 82.77 crore for year under review as compared to Rs 167.16 crore for year ended March 31, 2020.

For the year ended March 31, 2021, on the consolidated basis, the company has reported a rise of 4.17% in its net profit and share of associate’s profit at Rs 342.84 crore as compared to Rs 329.12 crore for the previous year. However, total income of the company decreased by 49.93% at Rs 83.79 crore for year under review as compared to Rs 167.33 crore for year ended March 31, 2020.

Alembic Share Price

124.15 0.70 (0.57%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.